Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...

Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...

Palliative care consultations helped patients with esophageal cancer at end-of-life experience better quality of life and ...

Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

New statistics show Britain has the highest cases of esophageal cancer in the entire Europe, mostly for those under 40 years ...

Two final-year Medicine students design consultation tools thanks to a grant from the Cris Foundation against Cancer. After a ...

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

Leap Therapeutics, Inc.'s DKN-01 trial results show mixed outcomes in cancer treatment, prompting potential future funding ...

“Locally advanced unresectable or metastatic gastroesophageal adenocarcinoma remains a challenging disease to treat and a leading cause of cancer death worldwide,” Dr. Gregory Lubiniecki, Vice ...

The addition of lenvatinib and pembrolizumab to chemotherapy did not extend OS for certain patients with advanced ...

A review of guidelines, expert consensus statements, and original studies identified self-management strategies for GERS after gastroesophageal cancer surgery.